Presenters:
Deborah Dowell, MD, MPH
Senior Medical Advisor
Division of Unintentional Injury Prevention
National Center for Injury Control and Prevention
Centers for Disease Control and Prevention
James Robinson, MD, PhD
Clinical Professor
Department of Rehabilitation Medicine
Center for Pain Relief and Bone and Joint Clinics
University of Washington
David J. Tauben, MD, FACP
Chief, Division of Pain Medicine
Clinical Professor
Hughes M & Katherine G Blake Endowed Professor
Departments of Medicine and Anesthesia & Pain Medicine
University of Washington
Accreditation
Statements:
CME: The Centers for Disease Control and
Prevention is accredited by the Accreditation Council for Continuing Medical
Education (ACCME®) to provide continuing medical education for physicians.
The Centers for Disease Control and Prevention designates
this live activity for a maximum of 1.0 AMA
PRA Category 1 Credit™. Physicians should only claim credit commensurate with
the extent of their participation in the activity.
CNE: The Centers for Disease Control and
Prevention is accredited as a provider of Continuing Nursing Education by the
American Nurses Credentialing Center's Commission on Accreditation.
This activity provides 1.0 contact hour.
IACET CEU: The Centers for Disease Control
and Prevention is authorized by IACET to offer 1.0 CEU's for
this program.
CECH: Sponsored by the Centers for Disease
Control and Prevention, a designated provider of continuing education contact
hours (CECH) in health education by the National Commission for Health
Education Credentialing, Inc. This program is designed for Certified Health
Education Specialists (CHES) and/or Master Certified Health Education
Specialists (MCHES) to receive up to 1.0 total Category I
continuing education contact hours. Maximum advanced level continuing
education contact hours available are 0. CDC provider number
98614.
ACPE: The Centers for Disease Control and
Prevention is accredited by the Accreditation Council for Pharmacy Education
as a provider of continuing pharmacy education. This program is a designated
event for pharmacists to receive 0.1 CEUs
in pharmacy education. The Universal Activity Number is 0387-0000-16-149-L04-Pand
enduring 0387-0000-16-149-H04-P course category.
Course Category: This activity has been designated as
knowledge-based.
Once credit is claimed, an unofficial statement of credit is
immediately available on TCEOnline. Official credit will be uploaded within
60 days on the NABP/CPE Monitor.
AAVSB/RACE: This program was reviewed and
approved by the AAVSB RACE program for 1.0 hours of
continuing education in the jurisdictions which recognize AAVSB RACE
approval. Please contact the AAVSB RACE Program at race@aavsb.org if you have any
comments/concerns regarding this program’s validity or relevancy to the
veterinary profession.
CPH:The Centers for Disease Control
and Prevention is a pre-approved provider of Certified in Public Health (CPH)
recertification credits and is authorized to offer 1 CPH recertification
credit for this program.
CDC is an approved provider of CPH Recertification Credits
by the National Board of Public Health Examiners. Effective October 1, 2013,
the National Board of Public Health Examiners (NBPHE) accepts continuing
education units (CEU) for CPH recertification credits from CDC. Please select
CEU as your choice for continuing education when registering for a course on
TCEOnline. Learners seeking CPH should use the guidelines provided by the
NBPHE for calculating recertification credits. For assistance please contact
NBPHE at http://www.NBPHE.org.
There is no cost for this program.
DISCLOSURE: In compliance with continuing
education requirements, CDC, our planners, our presenters, and their
spouses/partners wish to disclose they have no financial interests or other
relationships with the manufacturers of commercial products, suppliers of
commercial services, or commercial supporters. Planners have reviewed content
to ensure there is no bias.
The presentation will not include any discussion of the unlabeled use of a
product or a product under investigational use.
CDC does not accept commercial support.
|